≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Seminoma of testis

Endpoint Browser

C3_TESTIS_SEMINOMA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C62.01&, C62.11&, C62.91&
  • Hospital discharge: ICD-9 — 186A
  • Cause of death: ICD-10 — C62.01&, C62.11&, C62.91&
  • Cause of death: ICD-9 — 186A
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — 9061
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

362

4. Check minimum number of events

None

362

5. Include endpoints

None

362

6. Filter based on genotype QC (FinnGen only)

362

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Seminoma of testis based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 362 - 362
Unadjusted period prevalence (%) 0.16 - 0.16
Median age at first event (years) 37.93 - 37.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
328
Matched controls
3280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
309.6
246
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
264.9
217
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
581.9
255.8
224
12
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
444.8
197.7
180
9
JN4BD
NOMESCO Finland
Extensive body CT
14.8
74.6
137
151
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
63.6
59
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
351.9
59.3
58
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
20.7
57.5
88
57
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
49.2
46
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
41.5
39
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
159.9
40.8
42
*
130
Kela drug reimbursment
Malignant tumour
8.4
37.6
90
141
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
36.1
34
*
JN4AD
NOMESCO Finland
Body CT examination
8.9
33.6
76
107
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
32.7
107
254
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
126.0
32.3
34
*
18699
ICD-8 Finland
Malignant neoplasm of testis
331.3
30.3
30
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
88.5
29.3
32
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
306.3
28.2
28
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
306.3
28.2
28
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
109.7
28.2
30
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
25.1
187
908
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
25.0
77
164
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.1
23.6
34
17
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
23.2
22
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.5
18.0
25
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
17.9
138
640
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
17.9
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.4
17.6
55
117
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.5
17.2
38
50
A04AA02
ATC
granisetron; systemic, transdermal
7.0
15.3
38
60
L03AA02
ATC
filgrastim; parenteral
14.1
15.0
25
19
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
22.3
14.9
21
10
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
15.1
14.8
24
17
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.4
14.6
55
142
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
14.1
106
470
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
13.3
63
200
H02AB02
ATC
dexamethasone; systemic
4.5
12.3
44
108
D29.2
ICD-10 Finland
Benign neoplasm: Testis
48.5
12.0
14
*
E29.1
ICD-10 Finland
Testicular hypofunction
7.4
11.6
27
39
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
124.2
11.5
12
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
124.2
11.5
12
*
Y78
ICPC
Malign neopl male genital other
+∞
10.5
10
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
10.5
10
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
41.4
10.0
12
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
102.9
9.5
10
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
9.2
61
244
WX320
NOMESCO Finland
Spinalanesthesy
2.6
9.0
75
341
N46
ICD-10 Finland
Male infertility
5.2
8.9
27
56
N02AA05
ATC
oxycodone; systemic
3.0
8.9
54
204
KFA00
NOMESCO Finland
Exploration of testis
28.4
8.5
11
*
A04AA01
ATC
ondansetron; systemic, rectal
5.0
8.5
26
55
7513
FHL
Test prosthesis installation
92.3
8.5
9
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
11.2
8.4
15
14
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
8.4
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.2
7.9
14
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.4
7.6
14
14
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.6
263
2146
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
81.9
7.4
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.6
6.8
22
50
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
40.9
6.8
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.1
6.6
15
22
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.0
6.3
19
40
Y28
ICPC
Limited function/disability (Y)
18.4
6.3
9
5
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
6.3
6
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
27.2
6.3
8
*
ZX120
NOMESCO Finland
Intravenous
3.0
6.2
35
125
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
6.1
42
169
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
6.0
27
83
WZC30
NOMESCO Finland
Teaching
2.5
6.0
48
214

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
94
13
97.32
178.64
9.5
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
78
44
22.32
99.41
3.6
1.5
iu/l
16.7
8.8
2.30
69
33
(3009214) Lutropin [Units/volume] in Serum or Plasma
106
119
12.18
90.93
3.1
1.5
u/l
7.3
4.7
2.24
94
102
(3017446) Testosterone [Moles/volume] in Serum or Plasma
153
531
4.26
39.06
4.3
2.3
nmol/l
13.5
15.3
2.31
148
497
(4035726)
75
184
4.88
29.33
1.2
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
12
19.45
27.56
6.4
4.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
299
2045
3.66
20.96
12.0
8.2
u/l
76.4
77.5
0.21
294
1952
(3021879) Hepatitis B virus core Ab [Presence] in Serum
84
317
3.15
17.17
1.3
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
236
1541
2.53
15.62
11.9
10.2
e9/l
3.6
4.2
4.42
212
1361
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
38
92
4.50
14.79
1.4
2.4
%
102.0
85.5
4.74
38
86
(3015377) Calcium [Moles/volume] in Serum or Plasma
135
727
2.37
13.24
5.5
3.6
mmol/l
2.4
2.3
1.29
124
656
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
84
377
2.60
12.11
5.8
3.3
mmol/l
2.4
2.4
0.03
74
326
(40768804) Tissue Pathology biopsy report
148
863
2.21
11.72
2.3
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
126
690
2.27
11.62
3.7
3.0
e6/l
0.6
0.4
0.21
101
529
(3002582) Erythrocytes [#/volume] in Urine
135
765
2.22
11.42
3.8
3.0
e6/l
99.1
141.0
0.15
107
604
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
93
452
2.42
11.25
1.7
1.6
—
—
—
0
0
(3036489) Thrombin time
36
103
3.77
11.18
1.5
2.3
s
21.0
22.6
1.28
36
93
(40758558) Short blood count panel - Blood
116
640
2.20
10.31
10.4
6.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
142
848
2.11
10.29
4.3
3.5
e6/l
132.2
132.1
0.00
110
639
(42870588) Differential panel, method unspecified - Blood
148
901
2.09
10.17
6.4
6.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
83
400
2.39
10.14
3.6
2.9
e6/l
0.4
0.5
0.17
54
223
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
85
415
2.37
10.08
3.4
2.8
e6/l
1.1
1.2
0.07
56
238
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
149
915
2.07
9.95
3.9
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
1052
2.04
9.94
4.0
4.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
179
1180
2.02
9.78
9.6
10.0
e9/l
0.0
0.0
0.45
145
976
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
50
191
2.88
9.75
2.5
1.9
pmol/l
207.0
244.8
1.40
50
181
(3017143) Hepatitis C virus Ab [Presence] in Serum
91
464
2.28
9.73
1.8
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
218
1545
2.03
9.67
5.8
5.6
mmol/l
6.7
6.8
0.20
207
1476
(3002256) Pathology report gross observation
65
286
2.55
9.63
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
117
667
2.11
9.44
3.8
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
111
632
2.09
8.91
2.0
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
91
500
2.10
7.93
3.2
2.7
mosm/kgh2o
606.8
596.6
0.15
80
432
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
19
45
4.40
7.57
3.9
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
19
45
4.40
7.57
1.9
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
221
1656
1.86
7.44
4.3
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
174
1232
1.79
6.86
6.6
7.1
%
0.7
0.7
0.06
166
1181
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
73
3.45
6.82
4.1
3.3
u/ml
0.3
0.3
0.39
12
38
(3006315) Basophils [#/volume] in Blood
186
1348
1.78
6.74
6.5
6.9
e9/l
0.0
0.0
1.18
156
1189
(3006504) Eosinophils/100 leukocytes in Blood
177
1266
1.78
6.69
6.7
7.0
%
3.0
3.0
0.14
169
1209
(3003694) ABO and Rh group [Type] in Blood
114
714
1.87
6.68
1.4
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
155
1067
1.79
6.67
9.3
6.0
g/l
36.6
36.5
0.08
144
1005
(3019069) Monocytes/100 leukocytes in Blood
178
1277
1.77
6.65
7.2
7.3
%
8.8
9.0
0.20
169
1226
(3001604) Monocytes [#/volume] in Blood
185
1345
1.77
6.58
6.5
6.8
e9/l
0.6
0.6
0.73
155
1181
(3013115) Eosinophils [#/volume] in Blood
189
1388
1.76
6.44
6.7
7.3
e9/l
0.2
0.2
1.23
163
1238
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
162
1139
1.76
6.42
12.1
8.1
mmol/l
1.2
1.2
0.14
128
984
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
310
2662
2.15
6.20
19.6
12.0
ml/min/173m2
86.4
88.3
0.67
282
2211
(3019198) Lymphocytes [#/volume] in Blood
189
1398
1.74
6.20
6.4
6.9
e9/l
1.6
1.9
3.90
162
1251
(3002030) Lymphocytes/100 leukocytes in Blood
181
1327
1.73
6.09
6.8
6.9
%
26.6
27.6
0.57
173
1269
(3000850) Epithelial cells [#/volume] in Urine
85
509
1.88
5.63
2.9
2.5
e6/l
3.2
2.8
0.19
75
450
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
90
556
1.82
5.38
1.8
1.8
mg/l
1.3
1.4
0.15
71
411
(3044640) Blood type and Crossmatch panel - Blood
109
713
1.76
5.37
3.4
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
175
1308
1.65
5.22
6.6
6.7
%
58.8
57.2
1.13
167
1255
(3032080) INR in Blood by Coagulation assay
143
1027
1.65
4.91
11.8
8.5
inr
1.4
1.2
0.50
33
323
(3019550) Sodium [Moles/volume] in Serum or Plasma
318
2822
2.04
4.82
22.0
15.2
mmol/l
139.4
139.7
1.58
311
2763
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
214
2.15
4.75
6.4
5.3
ug/l
4.1
69.2
1.05
36
181
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
143
1041
1.62
4.58
10.4
7.2
mmol/l
1.2
1.2
0.73
137
963
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
94
2.66
4.48
1.3
1.5
mu/l
228.8
286.9
0.93
24
88
(3023103) Potassium [Moles/volume] in Serum or Plasma
318
2839
1.99
4.48
22.3
15.2
mmol/l
4.0
4.0
0.27
310
2780
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
315
2827
1.88
4.02
19.8
13.3
mg/l
23.4
24.8
0.31
259
2227
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
28
4.02
4.00
1.5
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
263
1.86
3.48
3.4
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
82
2.52
3.44
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
64
2.74
3.44
1.6
1.6
ug/g
285.4
294.3
—
8
36
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
53
2.91
3.40
2.5
4.1
%
56.2
54.2
0.37
15
53
(3023368) Bacteria identified in Blood by Culture
104
749
1.55
3.31
8.0
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
124
2.18
3.23
1.1
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
80
546
1.60
3.21
3.2
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
38
210
1.90
3.19
2.0
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
99
711
1.54
3.18
3.5
2.5
umol/l
366.0
7779.9
2.97
91
634
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
50
2.87
3.12
2.6
3.8
e9/l
3.6
3.8
0.11
14
50
(40768795) Lymph node Pathology biopsy report
9
21
4.37
3.01
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
100
728
1.52
3.00
3.1
2.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
40
3.07
3.00
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
268
2368
1.51
2.93
25.8
16.2
%
13.5
13.5
0.16
263
2318
(4038314)
6
9
6.76
2.88
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
325
3008
1.79
2.88
19.4
11.8
—
—
—
0
0
(3012544) pH of Venous blood
42
250
1.77
2.81
6.5
4.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
19
85
2.30
2.75
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
191
1595
1.42
2.74
3.9
4.1
ug/l
1.7
2.0
0.60
169
1457
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
331
3090
1.83
2.70
14.4
9.8
u/l
32.3
33.9
0.85
326
3015
(3049717) Cytology report of Urine Cyto stain
20
94
2.19
2.60
3.6
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
101
2.15
2.58
5.6
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
150
1211
1.41
2.56
3.3
3.0
estimate
0.0
0.0
0.49
31
239
(3009261) Glucose [Presence] in Urine by Test strip
151
1221
1.41
2.55
3.3
3.1
estimate
0.0
0.0
0.00
30
226
(3002032) Base excess in Venous blood by calculation
40
242
1.73
2.54
6.8
4.4
mmol/l
1.1
1.6
0.46
33
200
(3018418) pH of Serum or Plasma
90
664
1.47
2.50
8.1
4.4
ph
7.4
7.4
0.25
30
126
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
16
4.44
2.48
3.7
1.8
u/l
176.0
192.6
—
7
16
(3021601) Nitrite [Presence] in Urine by Test strip
149
1209
1.40
2.45
5.1
4.2
estimate
0.0
0.0
0.00
31
248
(3021447) Carbon dioxide [Partial pressure] in Venous blood
40
245
1.71
2.44
6.8
4.4
kpa
5.9
5.8
0.04
40
239
(3051593) INR in Capillary blood by Coagulation assay
5
8
6.32
2.38
1.8
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
40
248
1.69
2.34
14.1
10.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
156
1.86
2.33
1.8
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
142
1.90
2.30
2.4
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
60
2.39
2.24
2.7
4.1
—
3939.6
—
0
7
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
184
1.75
2.12
1.6
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
63
2.27
2.03
5.8
4.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
21
3.38
1.97
1.3
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
262
1.59
1.92
4.2
2.8
u/l
27.9
221.6
0.55
34
227
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
246
2686
0.74
1.92
4.3
3.9
mmol/l
6.0
6.0
0.04
223
2491
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
7
22
3.22
1.89
1.3
1.5
nmol/l
0.2
0.2
—
7
17
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
79
2.07
1.88
3.4
2.0
—
—
—
0
0
(3019225) pH of Specimen
34
217
1.63
1.81
6.4
4.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
189
1.64
1.69
2.5
2.4
ml/min/173m2
68.6
67.7
0.03
16
78
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
91
1.91
1.63
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
91
1.91
1.63
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
402
1.43
1.60
2.9
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
644
1.35
1.57
2.9
3.2
ng/l
991.5
1171.3
0.28
70
531
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
146
1.69
1.55
9.6
15.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
146
1.69
1.55
1.5
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
27
2.62
1.52
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
119
991
1.30
1.51
3.3
3.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
21
2.89
1.51
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
271
2887
0.76
1.47
4.1
4.0
mmol/l
1.3
1.3
0.06
253
2714
(3026008) Bacteria identified in Urine by Culture
57
427
1.40
1.46
3.6
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
16
3.15
1.44
1.2
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
315
1.45
1.44
4.4
3.9
umol/l
8.9
12.1
0.45
37
280
(3022145) Colonoscopy Study observation
41
291
1.46
1.40
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
89
1.83
1.39
1.1
1.2
u/ml
325.1
277.7
0.27
11
58
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
47
345
1.42
1.35
4.8
2.5
%
24.6
25.3
0.14
41
305
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
38
0.00
1.35
0.0
1.3
—
300.0
—
0
6
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
276
2924
0.76
1.34
4.4
4.4
mmol/l
2.9
2.9
0.01
261
2741
(1616796) Gas panel - Central venous blood
11
54
2.07
1.34
6.2
3.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
340
3280
1.60
1.34
30.7
18.4
e9/l
231.4
238.8
1.64
335
3203
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
98
1.77
1.33
5.2
11.2
%
2.6
0.8
0.51
17
91
(3021901) Oxygen saturation in Capillary blood
9
43
2.12
1.31
5.6
2.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
102
848
1.28
1.30
3.3
2.9
u/l
54.7
57.3
0.37
93
805
(3035941) MCH [Entitic mass]
340
3284
1.58
1.28
30.6
18.3
pg
30.2
30.4
1.82
335
3245
(3038515) Glucose [Moles/volume] in Venous blood
9
44
2.07
1.27
5.0
3.7
mmol/l
7.6
7.7
—
9
44
(3013512) EKG study
84
683
1.30
1.27
5.2
3.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
340
3285
1.58
1.26
30.8
18.4
e12/l
4.7
4.8
3.09
334
3201
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
25
2.42
1.25
4.8
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
56
1.99
1.23
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
56
1.99
1.23
2.8
1.9
—
—
—
0
0
(4027681)
5
19
2.65
1.22
1.0
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
340
3288
1.56
1.22
30.8
18.4
e9/l
6.2
6.7
5.24
335
3206
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
120
1026
1.25
1.21
3.7
3.4
ng/l
70.2
53.3
0.19
84
675
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
26
2.33
1.19
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
102
1.70
1.18
3.1
4.4
g/l
0.1
0.2
—
9
57
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
274
2890
0.79
1.14
4.2
4.1
mmol/l
4.7
4.6
0.28
257
2734
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
73
1.81
1.12
2.4
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
162
0.54
1.11
1.4
5.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
41
1.97
1.09
2.5
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
41
1.97
1.09
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
21
2.40
1.09
1.8
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
153
1.54
1.09
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
121
1.60
1.08
2.7
3.3
pmol/l
4.7
4.6
0.20
14
109
(3024354) Oxygen [Partial pressure] in Venous blood
29
204
1.46
1.07
6.3
3.0
kpa
6.0
4.6
1.89
29
198
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
46
591
0.75
1.06
1.4
1.2
u/ml
7.1
1.1
0.61
14
182
(3000492) Spirometry study
46
353
1.35
1.04
2.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
52
407
1.32
1.04
2.1
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
60
1.86
1.04
1.5
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
204
1867
1.21
1.03
3.9
3.7
mm/h
12.8
9.7
1.49
187
1747
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
353
0.69
1.02
1.2
1.2
iu/ml
13.2
26.8
—
8
100
(3023520) Reticulocytes [#/volume] in Blood
28
198
1.45
1.01
3.6
2.9
e9/l
68.3
73.3
0.41
19
148
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
2.0
2.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
49
1.86
0.99
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
49
1.86
0.99
1.8
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
23
2.19
0.98
14.0
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
49
386
1.31
0.94
1.9
1.6
nmol/l
1014.9
1238.0
1.20
35
309
(3035637) Corticotropin [Mass/volume] in Plasma
6
27
2.24
0.94
1.3
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
27
2.24
0.94
2.7
3.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
27
2.24
0.94
2.7
3.0
mmol/l
4.3
4.1
—
6
27
(3035285) Chloride [Moles/volume] in Venous blood
6
27
2.24
0.94
2.7
3.0
mmol/l
105.2
104.3
—
6
27
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
267
2806
0.82
0.92
3.8
3.7
mmol/l
1.5
1.4
0.49
250
2636
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
28
2.16
0.92
1.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
103
0.48
0.90
1.4
1.4
—
68.0
—
0
10
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
(4268621)
6
31
1.95
0.84
3.7
2.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
31
1.95
0.84
4.0
2.9
—
27.9
—
0
7
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
57
1.78
0.84
1.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
294
1.33
0.84
3.7
4.0
%
29.4
29.1
0.06
29
219
(3028300) Cannabinoids [Presence] in Urine
17
246
0.68
0.81
1.2
3.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
245
0.68
0.80
1.2
3.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
11
66
1.69
0.79
5.6
2.4
mmol/l
25.2
24.6
0.21
11
59
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
48
1.68
0.79
1.3
1.3
—
—
—
0
0
(4146454)
0
26
0.00
0.78
0.0
2.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
244
0.68
0.78
1.2
3.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
34
1.78
0.76
3.2
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
100
879
1.19
0.75
1.8
1.8
pmol/l
95.4
94.7
0.05
59
504
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
24
2.10
0.75
1.0
1.3
mg/l
60.4
48.0
—
5
18
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
220
1.35
0.74
2.9
3.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
171
0.63
0.74
1.5
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
204
1902
1.17
0.74
3.5
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
41
328
1.28
0.73
2.1
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
60
1.69
0.73
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
26
1.94
0.71
14.0
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
238
0.70
0.70
1.2
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
376
1.26
0.70
1.9
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
110
1.48
0.69
3.3
2.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
27
1.86
0.68
1.2
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
15
102
1.49
0.68
5.5
10.8
%
1.9
1.6
0.23
15
94
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
91
0.54
0.68
1.0
1.1
—
3.4
—
0
13
(3016879) Cocaine [Presence] in Urine
16
225
0.70
0.68
1.3
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
128
1.43
0.67
3.3
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
78
1.56
0.66
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
45
542
0.81
0.65
1.3
1.4
g/l
2.3
2.6
0.82
30
376
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
128
0.62
0.65
1.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
207
2192
0.87
0.63
3.3
3.4
u/l
54.8
53.0
0.09
196
2094
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
79
1.54
0.63
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
79
1.54
0.63
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
51
1.58
0.61
1.0
1.1
—
104.6
—
0
15
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
18
242
0.73
0.60
2.2
2.4
g/l
10.1
10.8
0.48
18
219
(3009508) Creatinine [Moles/volume] in Urine
77
872
0.85
0.59
3.1
3.8
mmol/l
8.8
9.2
0.32
61
748
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
106
1.43
0.58
2.7
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
35
1.73
0.58
3.8
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
54
1.49
0.57
1.0
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
414
1.21
0.57
1.9
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
62
536
1.19
0.57
2.5
2.0
mg/l
3.0
3.1
0.11
53
470
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
276
1.26
0.56
6.6
7.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
244
2545
0.87
0.56
6.1
5.3
mmol/mol
39.5
39.9
0.27
222
2419
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.56
3.8
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
60
1.51
0.54
3.8
3.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
38
1.59
0.54
2.5
4.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
74
1.50
0.54
2.8
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
192
0.72
0.53
1.2
3.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
39
1.55
0.53
1.5
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
22
170
1.31
0.53
2.6
3.1
ng/l
86.5
149.5
0.96
22
147
(40760892) CBC W Ordered Manual Differential panel - Blood
73
645
1.17
0.52
5.0
5.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
916
1.14
0.51
2.5
2.6
ug/l
0.7
0.7
0.06
67
520
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
75
1.48
0.51
1.1
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
75
1.48
0.51
2.8
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
109
0.64
0.49
1.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
48
1.47
0.47
1.4
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
303
1.21
0.45
12.8
11.0
mmol/l
0.5
0.8
0.19
29
244
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
294
1.21
0.45
2.9
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
2.4
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
8
56
1.44
0.43
7.0
16.3
mmol/l
12.1
11.4
—
8
49
(3018572) Chloride [Moles/volume] in Blood
8
56
1.44
0.43
7.0
16.3
mmol/l
104.8
105.5
—
8
49
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
32
1.57
0.42
1.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
33
1.52
0.41
2.4
3.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.4
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
0.6
—
0
10
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
1.2
—
0
11
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
692
0.87
0.40
1.8
1.7
mmol/l
1.6
1.6
0.02
49
594
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
34
1.48
0.40
2.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
2.4
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
2.0
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
105
0.66
0.40
1.4
5.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
336
1.18
0.39
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
35
1.43
0.39
4.6
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
19
0.00
0.39
0.0
5.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
469
1.15
0.39
1.5
1.6
nmol/l
18.2
18.9
0.15
47
412
(3002173) Hemoglobin [Mass/volume] in Arterial blood
31
262
1.20
0.38
14.1
12.2
g/l
118.5
125.5
1.08
31
252
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
36
1.39
0.38
1.2
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
508
1.14
0.38
3.3
3.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
9
68
1.33
0.38
7.2
14.9
mmol/l
1.2
1.4
—
9
56
(3020891) Body temperature
8
111
0.71
0.38
3.4
4.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
301
1.18
0.36
2.9
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
81
1.37
0.36
1.1
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
71
1.27
0.36
1.8
2.0
g/l
9.6
11.0
—
9
61
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
41
1.47
0.36
8.0
3.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
41
1.47
0.36
1.7
3.5
—
—
—
0
0
(4094501)
5
78
0.64
0.36
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
42
1.44
0.35
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
125
0.71
0.35
1.1
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
49
549
0.88
0.34
3.1
3.3
kg/l
1.0
1.0
—
10
62
(3001122) Ferritin [Mass/volume] in Serum or Plasma
102
951
1.10
0.33
4.0
2.6
ug/l
203.1
189.4
0.23
92
888
(3025159) Blasts/100 leukocytes in Blood
26
221
1.19
0.31
3.2
4.9
%
0.4
0.2
—
5
66
(3008152) Bicarbonate [Moles/volume] in Arterial blood
13
164
0.78
0.31
8.5
11.1
mmol/l
24.0
24.4
0.22
13
152
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
93
1.30
0.30
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
55
1.28
0.30
1.3
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
112
1.26
0.28
3.1
3.1
mmol/l
22.8
25.0
1.36
14
105
(3052851) Hemolysis interference index of Serum or Plasma
10
76
1.32
0.28
13.1
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
118
1245
0.92
0.28
2.8
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
17
204
0.83
0.27
1.3
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
67
1.20
0.26
1.7
2.1
g/l
0.1
0.9
—
8
60
(3021440) Promyelocytes/100 leukocytes in Blood
27
235
1.16
0.26
3.2
4.7
%
0.0
0.2
—
6
78
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
72
1.26
0.26
1.1
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
69
742
0.91
0.25
2.6
2.2
u/l
127.0
266.8
3.88
69
703
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
75
1.21
0.25
1.8
2.2
—
1.3
—
0
10
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
96
1.26
0.25
3.8
2.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
77
1.17
0.24
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
79
1.27
0.22
1.6
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
20.0
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
105
0.76
0.21
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
12
0.00
0.21
0.0
1.3
—
1.1
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
13
0.00
0.21
0.0
2.8
—
27.4
—
0
13
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
187
0.85
0.20
1.3
1.6
g/l
1.2
1.3
0.03
16
173
(3017181) Myelocytes/100 leukocytes in Blood
28
250
1.13
0.20
3.6
4.7
%
1.7
0.9
—
6
85
(3020874) Milk IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.5
—
0
5
(3044290) Cell count panel - Cerebral spinal fluid
6
49
1.23
0.20
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
50
1.20
0.20
1.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
16
186
0.85
0.19
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
51
1.18
0.19
1.7
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
196
0.86
0.19
3.2
3.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
59
1.19
0.18
6.1
2.8
kpa
9.2
8.7
—
7
59
(3013290) Carbon dioxide [Partial pressure] in Blood
7
59
1.19
0.18
6.1
2.8
kpa
5.3
5.0
—
7
59
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
7
62
1.13
0.17
1.9
1.8
g/l
36.0
37.8
—
7
51
(3022621) pH of Urine by Test strip
15
129
1.17
0.17
3.3
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
283
2790
1.07
0.17
24.6
13.4
%
40.8
42.5
2.22
225
2210
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
130
1256
1.05
0.16
3.0
3.7
%
22.8
21.2
0.55
57
506
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
141
0.85
0.16
1.2
1.4
—
8.3
—
0
9
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
227
2314
0.95
0.16
4.1
3.5
mu/l
1.9
2.4
0.45
203
2135
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
73
1.10
0.16
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
479
1.08
0.15
1.6
1.7
pmol/l
402.9
411.6
0.13
40
420
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
19
171
1.12
0.12
1.9
2.8
g/l
64.5
67.1
0.78
19
158
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.2
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
176
0.90
0.09
6.0
7.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
75
775
0.96
0.09
4.1
4.4
mg/mmol
10.4
11.5
0.09
49
540
(3012516) Albumin [Mass/volume] in Urine
71
734
0.96
0.09
3.2
3.6
mg/l
52.6
321.4
1.21
49
514
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
55
1.09
0.09
4.2
2.1
g/l
1.1
1.1
—
6
44
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.2
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
77
1.04
0.07
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
245
1.07
0.07
1.7
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
47
488
0.96
0.07
1.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
64
658
0.97
0.06
3.2
3.3
estimate
0.0
0.0
0.68
29
233
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
91
1.10
0.04
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
131
1.07
0.03
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
55
538
1.03
0.03
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
151
1.06
0.03
1.3
1.3
—
40.6
—
0
12
(3000494) Fungus identified in Specimen by Culture
34
350
0.97
0.03
1.8
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
93
918
1.02
0.03
2.9
2.2
nmol/l
73.0
71.4
0.22
85
844
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
179
1802
0.99
0.02
3.7
2.8
pmol/l
15.0
14.8
0.26
162
1642
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
378
0.98
0.01
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
210
2091
1.01
0.01
2.8
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
404
1.02
0.00
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
502
1.00
0.00
3.7
3.7
ng/l
286.4
932.2
1.25
39
377
(3004588) Protein electrophoresis panel - Serum or Plasma
14
145
0.96
0.00
1.8
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
255
0.98
0.00
1.5
1.4
—
—
—
0
0
(4010399)
18
184
0.98
0.00
1.2
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
134
0.97
0.00
1.4
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
147.3
—
0
9
(3045414) Leukocytes [Presence] in Urine
8
83
0.96
0.00
3.4
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.4
—
0.3
—
0
5
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
130
1.00
0.00
1.1
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
4.0
—
3.8
—
0
5
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
34.5
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
2.0
—
0
7
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
11.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3010421) pH of Blood
7
72
0.97
0.00
6.9
2.8
ph
7.4
7.4
—
7
59
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
18.4
—
0
7
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.6
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
96
0.94
0.00
3.0
3.9
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
6
0.00
0.00
0.0
3.0
—
15.0
—
0
6
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
89.4
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
92
0.98
0.00
1.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4015189)
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
79
1.01
0.00
2.9
2.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
2.6
—
10585.9
—
0
7
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
12.7
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS_SEMINOMA – Seminoma of testis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).